Min Luo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Machine Learning

Top Venues

Clinical and translational medicine

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yuwei Li, Chaoxiong Wang, Zhigang Lu, Min Luo
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy. Clinical and translational medicine 14 (1) (2024)
Yuwei Li, Chaoxiong Wang, Zhigang Lu, Min Luo
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy. Clinical and translational medicine 14 (1) (2024)
Yuwei Li, Chaoxiong Wang, Zhigang Lu, Min Luo
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy. Clinical and translational medicine 14 (1) (2024)
Yuwei Li, Chaoxiong Wang, Zhigang Lu, Min Luo
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy. Clinical and translational medicine 14 (1) (2024)
Chaoxiong Wang, Xichen Zheng, Jinlan Zhang, Xiaoyi Jiang, Jia Wang, Yuwei Li, Xiaonan Li, Guanghui Shen, Jiayin Peng, Peixuan Zheng, Yunqing Gu, Jiaojiao Chen, Moubin Lin, Changwen Deng, Hai Gao, Zhigang Lu, Yun Zhao, Min Luo
CD300ld on neutrophils is required for tumour-driven immune suppression. Nature (2023)
Xiaoyi Jiang, Jian Wang, Xichen Zheng, Zhida Liu, Xinyu Zhang, Yuwei Li, Jonathan Wilhelm, Jun Cao, Gang Huang, Jinlan Zhang, Baran Sumer, Jayanthi Lea, Zhigang Lu, Jinming Gao, Min Luo
Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. Journal for immunotherapy of cancer 10 (5) (2022)